Looked thru the website just now. Hudson's pix is there, but I found perhaps the last remaining mistake. In the Company Profile section:
"We are currently in a Phase II clinical trial with a drug for Hepatitis C infection and our..."
On another note, I think its a good sign that no one on either Avi chat room or board noticed the Ercole news which was announced at 4pm yesterday until early this morning. Hudson seems to have us all slightly stunned I think. That's a real good sign.
To say the least. The first professional CC and strategic move since I've owned an equity position(3 years)
It looks to me that we will be an ESPRIT company with some government therapeutic work on the side.
VERY DISAPPOINTING update on CABG. If 50% of the trial patients had AVI5126 and the other half placebo...I would never expect an increase in negative grafts regardless of the 'other' variables unless it was lab incompetency.
Is there a chance that since Cook is also using AVI5126 that we shouldn't bother expecting much from them and that DMD is THE ONLY near term hope.
I was amused to hear Timmons say 2008 should have a cash burn between $16-$19M. Suggests to me that all efforts will be on ESPRIT. Especially since he hugely downplayed any large government stockpiling contracts for the foreseeable future.